GIM
BPMC

Granahan Investment Management’s Blueprint Medicines BPMC Stock Holding History

Granahan Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-144,756
Closed -$12.8M – 157
2025
Q1 		$12.8M Buy
144,756
+2,866
+2% +$280K 0.64% 52
2024
Q4 		$12.4M Buy
141,890
+10,744
+8% +$984K 0.52% 55
2024
Q3 		$12.1M Sell
131,146
-8,586
-6% -$853K 0.48% 66
2024
Q2 		$15.1M Sell
139,732
-39,585
-22% -$3.96M 0.6% 48
2024
Q1 		$17M Buy
179,317
+11,810
+7% +$1.01M 0.6% 53
2023
Q4 		$15.5M Sell
167,507
-61,740
-27% -$4M 0.51% 62
2023
Q3 		$11.5M Buy
229,247
+44,744
+24% +$2.39M 0.41% 74
2023
Q2 		$11.7M Sell
184,503
-47,716
-21% -$2.59M 0.36% 77
2023
Q1 		$10.4M Buy
232,219
+7,405
+3% +$334K 0.32% 87
2022
Q4 		$9.85M Buy
224,814
+80,637
+56% +$3.87M 0.3% 92
2022
Q3 		$9.5M Buy
144,177
+40,531
+39% +$2.6M 0.31% 89
2022
Q2 		$5.24M Sell
103,646
-53,000
-34% -$3.1M 0.18% 117
2022
Q1 		$10M Buy
156,646
+105,921
+209% +$7.6M 0.25% 90
2021
Q4 		$5.43M Sell
50,725
-2,072
-4% -$217K 0.11% 147
2021
Q3 		$5.43M Sell
52,797
-9,481
-15% -$883K 0.1% 143
2021
Q2 		$5.48M Buy
62,278
+3,371
+6% +$309K 0.1% 149
2021
Q1 		$5.73M Sell
58,907
-38,875
-40% -$3.88M 0.12% 133
2020
Q4 		$11M Sell
97,782
-30,777
-24% -$3.24M 0.25% 85
2020
Q3 		$11.9M Buy
128,559
+17,833
+16% +$1.37M 0.4% 73
2020
Q2 		$8.64M Buy
+110,726
New +$7.49M 0.31% 89

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Granahan Investment Management's BPMC Position: Q2 2025 in Review

Granahan Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 144,756 shares — an estimated $12.8M sold.

Granahan Investment Management first reported a position in BPMC in Q2 2020 and held it in 20 quarters. The position peaked at $17M in Q1 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Granahan Investment Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Granahan Investment Management sold 144,756 Blueprint Medicines shares in Q2 2025, an estimated $12.8M.
  • Granahan Investment Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 20 quarters.
  • Granahan Investment Management's Blueprint Medicines position peaked at $17M in Q1 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Granahan Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.